SynthesisFrontiers in endocrinology2026
The impact of SGLT2 inhibitors on renal outcomes in patients with type 2 diabetes and chronic kidney disease: systematic review and meta-analysis.
Ya Su et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.